Skip to main content
SleepCited

トリプトファン 不眠症

A

合計32,701名の参加者を対象とした79件の研究(メタアナリシス3件、RCT 4件を含む)に基づく。79件中54件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtryptophan\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Tryptophan is supported by extensive research as a supplement that may help with insomnia, working through its natural role as a building block for sleep-regulating brain chemicals.

  • 79 studies with 32,701 participants provide a large evidence base
  • About 68% of studies show positive effects on insomnia
  • Tryptophan is the natural precursor to both serotonin and melatonin
  • Both supplementation and dietary approaches to increasing tryptophan have been studied

Key Study Findings

Review
Effects of L-tryptophan on sleepiness and on sleep.
Dose: 1 g or more vs: Placebo 効果: Increase in subjective sleepiness; decrease in sleep latency
animal study
Compound Chaijin Jieyu Fang alleviates insomnia complicated with depression by reshaping actinobacteria to inhibit neuronal …
Dose: Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified vs: Placebo 効果: None None
Controlled Clinical Trial n=32 12 weeks Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis 効果: None 0.0449 (itch), 0.0089 (insomni

対象集団: Patients with atopic dermatitis and mild-moderate negative emotions

bioinformatics/animal study
Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson's disease and insomnia.
Dose: Not applicable (bioinformatics analysis + animal experiment validation; no human intervention) vs: Placebo 効果: None None
cross-sectional study n=165
Characteristics and influencing factors of gut microbiota in population with sleep disorders.
Dose: not applicable (observational study) vs: Placebo 効果: None None
animal study 2 weeks
A non-pharmacological intervention for insomnia: tryptophan-fructooligosaccharides combination improves sleep in mice via anti-inflammation and gut …
Dose: tryptophan+FOS (TF) low dose: 10 mg/kg tryptophan + 500 mg/kg FOS; high dose: 20 mg/kg + 1000 mg/kg vs: Placebo 効果: sleep duration improved by 81.0% (caffeine model, HD, p<0.001); 50.8% (PCPA model, HD, p<0.01); TNFα <0.001 (caffeine model); <0.01

Key Statistics

84

研究数

32969

参加者数

Positive

A

グレード

Referenced Papers

Journal of psychiatric … None 102 件の引用
Psychiatry investigation 2024 24 件の引用
BMC women's health 2024 12 件の引用
Asia Pacific journal … 2024 1 件の引用
Child and adolescent … 2023 5 件の引用
Journal of personalized … 2023 4 件の引用
Annual review of … 2021 149 件の引用
Frontiers in bioengineering … 2021 18 件の引用
Combinatorial chemistry & … 2021 16 件の引用
Nutricion hospitalaria 2021 3 件の引用
Journal of exercise … 2019 26 件の引用
The Cochrane database … 2019 24 件の引用
Pathologie-biologie 2014 74 件の引用
The Cochrane database … 2014 56 件の引用
Current signal transduction … 2014 41 件の引用
Profiles of drug … 2013 26 件の引用
Sleep medicine reviews 2011 317 件の引用
Journal of ethnopharmacology 2008 55 件の引用
Primary care 2002 43 件の引用
Zeitschrift fur arztliche … 2001 3 件の引用
Medical science monitor … 2000 11 件の引用
Bangladesh Medical Research … 2000
Psychosomatic medicine 1999 136 件の引用
Alternative medicine review … 1998 216 件の引用
Alternative medicine review … 1998
Wisconsin medical journal 1990
American family physician 1987
Annual review of … 1975 27 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

sleep:
250-1,000 mg, before bed

上限量: Not established; previously recalled (1989) due to contamination

研究で検討された用量

用量 期間 効果 N
1 g or more -- Positive --
Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified -- Positive --
None 12 weeks Positive 32
Not applicable (bioinformatics analysis + animal experiment validation; no human intervention) -- Neutral --
not applicable (observational study) -- Neutral 165
tryptophan+FOS (TF) low dose: 10 mg/kg tryptophan + 500 mg/kg FOS; high dose: 20 mg/kg + 1000 mg/kg 2 weeks Positive --
Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components -- Positive --
tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral -- Positive --

推奨摂取タイミング: 30-60 minutes before bed, ideally on a light stomach

Safety & Side Effects

報告されている副作用

  • Nausea
  • Diarrhea
  • Drowsiness
  • Dry mouth
  • Blurred vision

既知の相互作用

  • SSRIs/SNRIs — risk of serotonin syndrome
  • MAOIs — dangerous serotonin accumulation
  • Sedatives — additive drowsiness

耐容上限摂取量: Not established; previously recalled (1989) due to contamination

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does トリプトファン help with 不眠症?
Based on 84 studies with 32,969 participants, there is strong evidence from multiple clinical trials that トリプトファン may support 不眠症 management. Our evidence grade is A (Strong Evidence).
How much トリプトファン should I take for 不眠症?
Studies have used various dosages. A commonly studied range is 250-1,000 mg, before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of トリプトファン?
Reported side effects may include Nausea, Diarrhea, Drowsiness, Dry mouth. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for トリプトファン and 不眠症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 84 peer-reviewed studies with 32,969 total participants. The overall direction of effect is positive.

Related Evidence

トリプトファン 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。